Back to search

Matrix metalloproteinases and their tissue inhibitors in pressure-overloaded human myocardium during heart failure progression

Data up to Jan 2025

Published2004
Citations187
References25

Total Citations Per Year

Abstract

References (25)

Progression From Compensated Hypertrophy to Failure in the Pressure-Overloaded Human Heart

2003 • 1,023 citations

Matrix Metalloproteinase Inhibition After Myocardial Infarction

2001 • 596 citations

The Soluble Catalytic Domain of Membrane Type 1 Matrix Metalloproteinase Cleaves the Propeptide of Progelatinase A and Initiates Autoproteolytic Activation

1996 • 564 citations

Molecular Cloning and Characterization of Human Tissue Inhibitor of Metalloproteinase 4

1996 • 547 citations

Gene Expression in Fibroblasts and Fibrosis

2002 • 508 citations

A Matrix Metalloproteinase Induction/Activation System Exists in the Human Left Ventricular Myocardium and Is Upregulated in Heart Failure

2000 • 470 citations

Differential Expression of Tissue Inhibitors of Metalloproteinases in the Failing Human Heart

1998 • 376 citations

Time-Dependent Changes in Matrix Metalloproteinase Activity and Expression During the Progression of Congestive Heart Failure

1998 • 372 citations

Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat

2000 • 293 citations

Fibrosis of the left atria during progression of heart failure is associated with increased matrix metalloproteinases in the rat

2003 • 190 citations

Excessive activation of matrix metalloproteinases coincides with left ventricular remodeling during transition from hypertrophy to heart failure in hypertensive rats

2002 • 142 citations

Cardiac remodelling in end stage heart failure: upregulation of matrix metalloproteinase (MMP) irrespective of the underlying disease, and evidence for a direct inhibitory effect of ACE inhibitors on MMP

2002 • 138 citations

MMP/TIMP expression in spontaneously hypertensive heart failure rats: the effect of ACE- and MMP-inhibition

2000 • 136 citations

Differential effects of pressure or volume overload on myocardial MMP levels and inhibitory control

2000 • 128 citations

Temporal regulation of extracellular matrix components in transition from compensatory hypertrophy to decompensatory heart failure

1999 • 122 citations

Cell cycle-associated accumulation of tissue inhibitor of metalloproteinases-1 (TIMP-1) in the nuclei of human gingival fibroblasts

1998 • 98 citations

MMP inhibition modulates TNF-α transgenic mouse phenotype early in the development of heart failure

2002 • 74 citations

Expression of Matrix Metalloproteinases in Patients With Acute Myocardial Infarction

2001 • 70 citations

Activation of gelatinase–tissue-inhibitors-of-metalloproteinase complexes by matrilysin

1998 • 68 citations

Regression of Left Ventricular Hypertrophy After Surgical Therapy for Aortic Stenosis Is Associated With Changes in Extracellular Matrix Gene Expression

2001 • 53 citations

Changes in collagen metabolism in response to endothelin-1: Evidence for fibroblast heterogeneity

1996 • 46 citations

Matrix metalloproteinases and tissue inhibitors of metalloproteinases in hamster aortic atherosclerosis: correlation with in-situ zymography

2002 • 33 citations

Fibroblast subpopulations in intra‐oral wound healing

2003 • 23 citations

Defects in Matrix Metalloproteinase Inhibitory Stoichiometry and Selective MMP Induction in Patients with Nonischemic or Ischemic Dilated Cardiomyopathy

1999 • 19 citations

Remodeling der extrazellulären Matrix bei dilatativer Kardiomyopathie

2002 • 18 citations

Cited By (0)

Loading...